(MENAFN- America News Hour) Urinalysis
market size was valued at over USD 1 billion in 2015, and is set to exceed USD
2.1 billion by 2023. Government initiatives to improve the health index
accompanied by growing medicinal awareness are forecast to stimulate global
urinalysis market growth. U.S. urinalysis market spurred North American
industry revenue to over 510 million in 2015. Automated urine sediment
analyzers amenities such as fluorescence flow cytometry and digital imaging
(morphology) along with increase in medical spending were the chief growth
drivers.
Asia
Pacific urinalysis market share may witness growth of over 7% CAGR up to 2023,
mainly due to demand across India and China. Increase in advanced urine
analyzers adoption coupled with large number of untapped population is forecast
to present attractive growth opportunities.
Urinalysis
test is a convenient and effective method to analyze urine sample to detect
diabetes, urinary tract infection, and kidney disease. This test is also
conducted to identify back pain, painful urination and abdominal pain symptoms.
Rising kidney diseases owing to change in food consumption habits accompanied
by growing concerns from geriatric population are among major industry drivers.
Get a
TOC of this Report@https://www.gminsights.com/request-toc/upcoming/439
Instruments
and consumables are the two key product types. Consumables segment led global
revenue; increasing test strips and reagents usage due self awareness were the
key reasons to influence demand. Dipstick, disposables and reagents are the
major consumables in the industry.
Growing
incidences of chronic diseases due to change in lifestyle and environment has
resulted in the need for quick and advanced tests. Dipstick is a diagnostic
tool to identify substances in the urine related to metabolic disorders, UTI,
and renal dysfunction.
Instrument
urinalysis market share is set to observe growth of over 6% CAGR up to 2023.
Biochemical, automated, and point-of-care (PoC) are the key instrument product
types. Technological innovation in automated urine sediment analyzers and self
urine strip readers are among key factors to enhance industry growth.
Wireless
communication and compact PoC urinalysis instruments development facilitated
simultaneous single-level access report results in hospitals is another
promising factor to foster demand.
UTI,
kidney diseases, diabetes, liver diseases, and hypertension are major
applications. UTI application led global consumption and registered around 21%
of the global volume in 2015. High penetration in hospitals as it is a
frontline indicative tool, accompanied by growing medical awareness among women
may augment growth.
This
testing is used to diagnose several metabolic abnormalities and to detect
diseases such as chronic kidney disease, urinary bladder cancer, and diabetes.
Introduction of user-friendly, effective, and technologically advanced tools
have augmented demand in these applications.
End-use
segments include clinical laboratories, hospitals, home, research, and
academics. Clinical laboratories were the dominant segment and accounted for around
35% of the global share in 2015. Growing concerns pertaining to hygiene and
cleanliness accompanied by increase in number of hospitals and healthcare
centers should positively drive demand.
Point of
care and self testing growth owing to advanced automated testing is projected
to fuel home-based analysis growth. This segment is set to witness
approximately 7% CAGR up to 2023.
Middle
East & Africa urinalysis market is at a nascent stage; rising health
consciousness and regulatory shift in focus towards resolving unmet medical
needs is projected to result in considerable growth potential.
Affordable
Care Act (ACA) scheme implementation in the U.S. is forecast to result in
insurance coverage of more than 18 million people in the coming years. Government
policies to promote health awareness accompanied by health insurance industry
expansion may positively influence growth.
Browse
Report Summary @https://www.gminsights.com/industry-analysis/urinalysis-market
Inadequate
healthcare facilities and infrastructure in underdeveloped countries are growth
restraints. However, low urinalysis market price trend is forecast to meet the
growing demand from low-income countries; and enhance demand in untapped
regional industries due to the presence of large population.
Global
urinalysis market share is predicted to mainly be driven by mergers &
acquisitions and collaboration to expand regional presence. Key companies
include Alere, Bio-Rad, ARKRA, Mindray, Sysmex, Roche Diagnostics, and Siemens
Healthcare.
Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
MENAFN16072019007010068ID1098762720
-MENAFN16072019007010068ID1098762720-->
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.